European Partnership on One Health Antimicrobial Resistance

Calls

United Kingdom

EUP OHAMR joint transnational call 2026: National rules and requirements for applicants from United Kingdom.

The information below of the national rules and requirements is only a summary. Please visit the national websites and contact the respective national contact person for full details.

UK Research and Innovation are participating through both the Medical Research Council (MRC) and Innovate UK. Please note that there are separate sections about the MRC funding and about Innovate UK funding below.

Medical Research Council – United Kingdom Research and Innovation (MRC – UKRI)

Medical Research Council – United Kingdom Research and Innovation (MRC – UKRI), Department of Health and Social Care (DHSC)

Emma Mitchell

National/ Regional Financial Commitment: £1 million

Exchange Rate: £1: €1.15

Grant amount awarded to a project partner: Individual consortia may request up to a maximum of €230 000 (£200 000) MRC-UKRI funding, per application. This maximum amount refers to the 80% fEC value and not the 100% fEC value.

Expected number of funded proposals: 6

Eligible Topic(s): 3

Eligible One Health settings: MRC, part of UK Research and Innovation, and DHSC are able to support all research areas that fall within the remit of MRC and DHSC. Potential applicants are strongly advised to contact the MRC National contact (UKRI-AMR@ukri.org), in advance of making an application, to resolve any eligibility queries.

Eligible institutions

Applicants must be eligible to receive UKRI research funding. Details of eligibility for MRC funding can be found on the UKRI website, se link below.

Industrial partners may not request costs from MRC-UKRI. Any organisations that are using the UKRI Horizon Europe Participant Identification Code (PIC, which is 906446474) are not eligible for funding in this first EUP OHAMR call.

Eligible experimental approaches and disciplines

All work must fall within the specific remits of the MRC or of NIHR – work primarily within the remit of the other UKRI councils will not be supported and applicants are strongly encouraged to contact the MRC prior to submission to confirm remit and suitability.

All experimental approaches, including in vitro, in silico and in vivo pre-clinical, phase I or IIa clinical trials are eligible for funding.

Eligibility criteria for the Principal Investigator

Awards will be made through MRC on behalf of MRC and DHSC. Potential applicants are strongly advised to contact the National Call Secretariat, or the MRC-UKRI contact, in advance of making an application, to resolve any eligibility queries. 

For the purposes of this call, a ‘partner’ requesting funding from MRC-UKRI is a legal entity. Multiple researchers from the same legal entity form a single partner, but only one of these researchers should be named on the EUP OHAMR application form.

Applicants who intend to collaborate with industrial or other non-academic partners should note that any costs incurred, direct or otherwise, by these partners cannot be met by MRC and that these partners cannot claim funding. 

Eligible costs

The MRC-UKRI component of applications should use full economic costings (fEC). The total amount requested must be the 80% fEC value. The submitting organisations must agree to find the balance of fEC for the project from other resources. In the ’financial plan’ section of the EUP OHAMR application form, the ’sum requested’ is the 80% fEC amount. The ’total’ is the 100% fEC amount plus any further resources or in kind contributions.

  • Eligible costs include project-related costs incurred after the award start date, including: 
    • Project leads and Project co-Leads time 
    • Research and technical staff 
    • Estates and Indirect costs  
    • Animal costs 
    • Travel and Subsistence 
    • Equipment 
    • Consumables 
    • Recruitment and advertising costs for staff directly employed on the project 
    • Costs related to research data management  
    • NHS Research costs. 
  • Ineligible costs include:  
    • NHS support and NHS treatment costs  
    • PhD students  
    • Publication costs, including open access publication costs. 
    • Industrial partners 

Submission of the proposal at the national level

  • As well as the EUP OHAMR application form, MRC-UKRI applicants must also complete a UK Budget Proforma at both the pre-application and full application stage (please email UKRI-AMR@ukri.org to receive a form).
    • Costs should be included in pounds sterling (GBP) on the UK budget proforma and included on the OHAMR application form in Euros using an exchange rate of £1:€1.15.
    • Applicants should include a statement on the UK budget proforma to confirm the exchange rate used, and that costs are entered at 80% fEC according to standard Research Council funding policy.
  • Applications that incur excess treatment costs for studies involving patients will be required to complete a SoECAT form if invited for a full application. Please see the MRC Guidance for Applicants for further information.

Please note

If your consortium is conducting research with animals outside the UK, it must be conducted in accordance with welfare standards consistent with those in the UK, as in Responsibility in the use of animals in bioscience research. Ensure all named applicants in the UK and overseas are aware of this requirement. You must complete a template for each species used, at both the pre-application and full-application stage.

Please submit these additional forms separately to MRC-UKRI by emailing UKRI-AMR@ukri.org (including the consortium acronym and number); do not add them to the EUP OHAMR consortium application submissions.

Please note successful UK partners in transnational consortia will be required to upload a single application to UKRI within one month of the notice of award. This is a purely administrative step and will not be peer-reviewed again; this must exactly replicate the UKRI component of the EUP OHAMR application.

A single UKRI award will be issued to all UK partners within a consortium, who will be responsible for disseminating the funding as per the application. The UK partners must therefore identify which researcher is the lead UK applicant, who will be responsible for submitting the UKRI application and whose institution will be responsible for disbursing UKRI funds to any other UKRI-funded partners. 

Awards are subject to UKRI Terms and Conditions for funding. Award letters will include any additional terms and conditions specific to the call. 

Innovate UK – United Kingdom Research and Innovation

Innovate UK – United Kingdom Research and Innovation (IUK-UKRI)

Francesca Hodges

CC: future.medicines@iuk.ukri.org

UK Research and Innovation are participating through both the Medical Research Council (MRC) and Innovate UK. Please note that there are separate sections about the MRC funding and about Innovate UK funding below.National/ Regional Financial Commitment: £1,086,000

Grant amount awarded to a project partner: Applicants to IUK-UKRI funding may request up to a maximum of £361,000 or 70% of project cost (whichever is lower), per EUP OHAMR application. If more than one UK registered organisation is involved in a EUP OHAMR application, the figure above is the maximum funding available across all UK organisations.

Expected number of funded proposals: 3-6

Eligible Topic(s): 1, 2

Eligible One Health settings: IUK-UKRI are able to support all research areas that fall within the remit of IUK-UKRI. Potential applicants are strongly advised to contact the IUK-UKRI Innovation Lead for EUP OHAMR, Francesca Hodges, in advance of making an application, to resolve any eligibility queries.

Eligible institutions

Within the EUP OHAMR main call text, the term ‘consortium’ is used for the group of eligible partner organisations asking for funding and the term ‘Principal Investigator’ for a single person from each consortium partner organisation responsible for the implementation of tasks assigned.

For the purposes of outlining eligibility for IUK-UKRI funding, IUK-UKRI uses the term ‘UK main applicant’ for the UK registered partner organisation leading the IUK-UKRI funded component of the project. The UK main applicant must be a UK registered micro, small or medium-sized enterprise (SME). IUK-UKRI uses the term ‘UK collaborative organisation’ for any other UK registered partner organisation participating in the EUP OHAMR consortium as a partner. The UK collaborative organisation must be a UK registered SME, academic institution, research and technology organisation (RTO), public sector organisation, not for profit organisation, or charity.

UK registered SMEs are eligible to lead the IUK-UKRI funded component of the project as the UK main applicant or work as a UK collaborative organisation with another UK registered SME as the UK main applicant.

UK registered academic institutions, RTOs, public sector organisations, not for profit organisations, and charities cannot lead the IUK-UKRI funded component of the project as the UK main applicant and are not eligible to receive funding from IUK-UKRI to work alone. UK registered academic institutions, RTOs, public sector organisations, not for profit organisations, and charities are eligible to receive IUK-UKRI funding when applying as a UK collaborative organisation working alongside a UK registered SME as the UK main applicant.

Any organisations that are using the UKRI Horizon Europe Participant Identification Code (PIC, which is 906446474) are not eligible for funding through this call.

Eligible experimental approaches and disciplines

We will fund industrial research projects and experimental development projects, as defined in the IUK-UKRI guidance on categories of research.

Eligibility criteria for the Principal Investigator

Potential applicants are strongly advised to contact the IUK-UKRI contact, in advance of making an application, to resolve any eligibility queries. 

To be eligible for funding from IUK-UKRI, organisations must be a UK registered micro, small or medium-sized enterprise (SME). Any organisations that are using the UKRI Horizon Europe Participant Identification Code (PIC, which is 906446474) are not eligible for funding through this call.

Please see the Innovate UK guidance for applicants below for full information of eligibility and resourcing of grants. 

Eligible costs

Applicants to IUK-UKRI funding may request up to a maximum of £361,000 or 70% of project cost (whichever is lower), per application. We will fund industrial research projects and experimental development projects, as defined in the Innovate UK guidance on categories of research.

Please see the Innovate UK Guidance for Applicants for full information of eligibility and resourcing of grants. For full details on what costs you can claim see the Innovate UK project costs guidance for non-academic organisations. 

Submission of the proposal at the national level

If you have any queries, need clarification on anything, or would like further information prior to submitting your proposal to the European Partnership on One Health AMR (EUP OHAMR), please contact the IUK-UKRI Innovation Lead Francesca Hodges, see contact information above.

At the point of submitting your proposal to the EUP OHAMR:

  • Contact the IUK-UKRI Innovation Lead for information on what needs to be submitted to IUK-UKRI which is likely to include a IUK-UKRI Budget Proforma.
  • Costs should be included in pounds sterling (GBP) on the UK budget proforma and included on the EUP OHAMR application form in Euros (EUR) using an exchange rate of £1: €1.15.
  • Applicants should include a statement on the IUK-UKRI budget proforma to confirm the exchange rate used, and that costs are entered according to standard IUK-UKRI funding rules.

Projects selected for funding:

  • Successful IUK-UKRI funded partners in transnational consortia will be required to submit an IUK-UKRI application.
  • This must replicate the IUK-UKRI component of the EUP OHAMR application and will not be peer-reviewed.
  • The IUK-UKRI funded partners must therefore identify which participant is the lead IUK-UKRI funded applicant, who will be responsible for submitting the IUK-UKRI Innovation Funding Service (IFS).

Awards are subject to Innovate UK funding rules. Award letters will include any additional terms and conditions specific to the call.